back to Meetings page
- IMMPACT-IX
- June 13-14, 2008
- Ritz Carlton Pentagon City
- Arlington, Virginia
Co-chairs:- Dennis C. Turk, PhD (University of Washington)
- Robert H. Dworkin, PhD (University of Rochester)
- Academia Participants
- Ralf Baron, Dr med (University of Kiel)
- Paul J. Desjardins, DMD, PhD (Wyeth)
- John T. Farrar, MD (University of Pennsylvania)
- Marc Gastonguay, PhD (Metrum Research Group)
- Ian Gilron, MD (Queen's University)
- Eija A. Kalso, MD, PhD (Helsinki University, Finland)
- Nathaniel P. Katz, MD (Tufts University Medical School)
- Mitchell B. Max, MD (University of Pittsburgh)
- Michael P. McDermott, PhD (University of Rochester)
- Henry J. McQuay, MD (University of Oxford, United Kingdom)
- Cyrus Mehta, PhD (Cytel)
- Sarah Peirce-Sandner (University of Rochester)
- Karin L. Petersen, MD (University of California San Francisco)
- Srinivasa N. Raja, MD (Johns Hopkins University)
- Bernard M. Ravina, MD (University of Rochester)
- Andrew S. Rice, MD (Imperial College London, United Kingdom)
- Michael C. Rowbotham, MD (University of California San Francisco)
- Cristina Sampaio, MD, PhD (Faculdade de Medicina de Lisboa, Portugal)
- Stephen Senn, PhD (University of Glasgow, United Kingdom)
- Soren Sindrup, MD (Odense University Hospital, Denmark)
- Charles Taylor, PhD (CP Taylor Consulting)
- Rolf-Detlef Treede, Dr med (University of Heidelberg, Germany)
- Mark S. Wallace, MD (University of California San Diego)
- Government Participants
- Ann Costello, DMD, PhD (US Food and Drug Administration)
- Raymond Dionne, DDS, PhD (National Institute of Health)
- Peter R. Gilbert, Sc M (National Institute of Health)
- Sharon Hertz, MD (US Food and Drug Administration)
- Robert D. Kerns, PhD (Veterans Administration and Yale University)
- Bob A. Rappaport, MD (US Food and Drug Administration)
- Patient Representative
- Penny Cowan (American Chronic Pain Association)
- Industry Participants
- Rozalina Dimitrova, MD, MPH (Allergan, Inc.)
- David J. Hewitt, MD (Merck & Company)
- Smriti Iyengar, PhD (Eli Lilly & Company)
- Gary W. Jay, MD (Schwarz Biosciences)
- Richard L. Leff, MD (AstraZeneca)
- Michael S. Leong, MD (Xenoport, Inc.)
- Christine Rauschkolb, MD, PhD (Johnson & Johnson)
- Joseph W. Stauffer, DO (Alpharma)
- Ilona Steigerwald, MD (Grunenthal GmbH)
- Jonathan Stewart, MB (GlaxoSmithKline)
- Jeffrey Tobias, MD (NeurogesX, Inc.)
- Richard E. White, PhD (Endo Pharmaceuticals)